MannKind | MNKD - EPS Earnings Per Share



MannKind reported $0.05 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.02 0.06 Nov/11 2025
FY2025Q2 Jun/2025 0.05 0.05 0.05 Aug/06 2025
FY2025Q1 Mar/2025 0.07 0.03 0.04 May/08 2025
FY2024Q4 Dec/2024 0.08 0.03 0.02 Feb/26 2025
FY2024Q3 Sep/2024 0.06 0.03 0.02 Nov/07 2024
FY2024Q2 Jun/2024 0.05 0.01 -0.02 Aug/07 2024
FY2024Q1 Mar/2024 0.04 0.03 -0.04 May/08 2024
FY2023Q4 Dec/2023 0.02 0.00 -0.07 Feb/27 2024
FY2023Q3 Sep/2023 0.02 -0.02 -0.06 Nov/07 2023
FY2023Q2 Jun/2023 -0.02 -0.04 -0.11 Aug/07 2023
FY2023Q1 Mar/2023 -0.04 -0.05 -0.1 May/09 2023
FY2022Q4 Dec/2022 -0.07 -0.06 -0.11 Feb/22 2023


Eps Change Date
Adma Biologics USD 0.14 0 Jun/2025
Dynavax Technologies USD 0.14 0.91 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Halozyme Therapeutics USD 1.54 0.43 Jun/2025
Insmed USD -1.7 0.28 Jun/2025
MacroGenics USD -0.57 0.32 Jun/2025
MannKind USD 0.05 0.01 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Novo Nordisk DKK 12.49 5.96 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Sanofi EUR 1.59 0.21 Jun/2025
Xencor USD -0.41 0.25 Jun/2025